企業プロフィール
Veracyte 株価・ニュース・カタリスト
- ティッカー:
- VCYT
- 取引所:
- NASDAQ
- セクター:
- MedTech
- 所在地:
- United States
株価パフォーマンス
42.08 USD (+2.01%)
終値
最終更新: 2026年8月17日
3.81B USD
時価総額
株価変動の要因
As of Aug 17, 2026, VCYT closed up 2.01% at $42.08. No new same-company headline was identified in the current news window.
企業概要
事業概要
Veracyte is a diagnostics company focused on genomic testing for cancer and other high-value clinical decisions. Its products help physicians make more informed treatment and biopsy decisions.
所在地とセクター分類
Headquartered in the United States and listed on NASDAQ, Veracyte sits in molecular diagnostics and precision medicine.
ビジネスモデルの特徴
The company depends on test volume, reimbursement, and the expansion of its oncology and pulmonary diagnostics franchises.
バイオ業界での位置付け
Veracyte is a diagnostics platform name whose stock moves more on adoption and reimbursement than on drug-development catalysts.
今後のカタリスト
- Veracyte's catalysts are Afirma, Decipher, and broader lung and bladder diagnostics adoption. The company improves when recurring testing and reimbursement keep expanding.
最近のニュース
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。